Trial
NCT05547438
Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
NeuroTrauma Sciences, LLC
Collaborators
Parexel
Condition
Acute Ischemic Stroke
Intervention
NTS-104 TRIS
Why stopped
a second generation product was found to be more relevant for development
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-24